N-methyl gatifloxacin aldehyde thiosemicarbazone derivative and preparation method and application thereof

A technology for afloxacin aldehyde amino reduction and gatifloxacin, which is applied to the preparation of N-methyl gatifloxacin aldehyde thiosemicarbazone derivatives, N-methyl gatifloxacin aldehyde thiosemicarbazones Derivatives, the field of application in antineoplastic drugs

Inactive Publication Date: 2017-06-13
HENAN UNIVERSITY
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of the aldehydes or ketones used to construct thiosemicarbazone molecules are common benzenes or heterocyclic aromatic aldehyde

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N-methyl gatifloxacin aldehyde thiosemicarbazone derivative and preparation method and application thereof
  • N-methyl gatifloxacin aldehyde thiosemicarbazone derivative and preparation method and application thereof
  • N-methyl gatifloxacin aldehyde thiosemicarbazone derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] 1-cyclopropyl-6-fluoro-7-(3,4-dimethyl-piperazin-1-yl)-8-methoxy-quinolin-4(1H)-one-3-aldehyde amino Thiourea (I-1), its chemical structural formula is:

[0034]

[0035] That is, the R substituent in formula I is an H atom.

[0036] The preparation method of this compound is: take N-methyl gatifloxacin aldehyde crude product (1.0g) shown in formula (V) and be dissolved in absolute ethanol (20 milliliters), add thiosemicarbazide (0.5g, 5.5mmol), Reflux reaction for 10 hours, filter while hot, wash twice with ethanol, wash twice with distilled water, dry, and recrystallize with DMF-ethanol (V:V=5:3) mixed solvent to obtain light yellow crystals of formula (I-1 ), to obtain product 0.53g, m.p.232~234℃. 1 H NMR (400MHz, DMSO-d 6 )δ: 11.78(s, 1H, CH=N), 9.06(s, 1H, 2-H), 8.53(s, 1H, NH), 8.45(s, 1H, NH 2 ),8.34(s,1H,NH 2 ), 7.87(d,1H,5-H), 3.83(s,3H,OCH 3 ), 4.15 (m, 1H, CH), 3.36~2.55 (mt, 7H, piperazine-H), 2.33 (s, 3H, N-CH 3 ), 1.36~1.12(m,7H,CH 3 and CH 2 C...

Embodiment 2

[0038] 1-cyclopropyl-6-fluoro-7-(3,4-dimethyl-piperazin-1-yl)-8-methoxy-quinolin-4(1H)-one-3-aldehyde acetal 4 -Methylthiosemicarbazide (I-2), its chemical structural formula is:

[0039]

[0040] That is, R in formula I is a methyl group.

[0041] The preparation method of this compound is: take N-methyl gatifloxacin aldehyde hydrazine dithioformic acid methyl ester (1.0g, 2.1mmol) shown in formula (VI) and dissolve in anhydrous n-butanol (20 ml ), after adding methylamine (0.53g, 17.0mmol), the mixed reactants were refluxed for 12 hours, filtered while hot, and the solid was washed twice with ethanol and twice with distilled water, dried, and washed with DMF-ethanol (V:V= 1:5) mixed solvent recrystallization to obtain 0.40 g of a yellow crystal product of formula (I-2), m.p.223-225°C. 1 H NMR (400MHz, DMSO-d 6 )δ: 11.76 (s, 1H, CH=N), 8.97 (s, 1H, 2-H), 8.44 (s, 1H, NH), 8.35 (s, 1H, NH), 7.88 (d, 1H, 5 -H), 4.16(m,1H,CH), 3.82(s,3H,OCH 3 ),3.53~3.36(m,7H, piperazine...

Embodiment 3

[0043] 1-cyclopropyl-6-fluoro-7-(3,4-dimethyl-piperazin-1-yl)-8-methoxy-quinolin-4(1H)-one-3-aldehyde acetal 4 - ethylthiosemicarbazide (I-3), its chemical structural formula is:

[0044]

[0045] That is, R in formula I is ethyl.

[0046] The preparation method of this compound is: take N-methyl gatifloxacin aldehyde hydrazine dithioformic acid methyl ester (1.0g, 2.1mmol) shown in formula (VI) and dissolve in anhydrous n-butanol (20 ml ), add ethylamine (0.77g, 17.0mmol) and then mix the reactants to reflux for 12 hours, filter while hot, wash the solid twice with ethanol and twice with distilled water, dry, and wash with DMF-ethanol (V:V= 1:5) mixed solvent recrystallization to obtain 0.42 g of yellow crystalline product of formula (I-3), m.p.225-227°C. 1 H NMR (400MHz, DMSO-d 6 )δ: 11.78 (s, 1H, CH=N), 8.93 (s, 1H, 2-H), 8.44 (s, 1H, NH), 8.37 (s, 1H, NH), 7.88 (d, 1H, 5 -H), 4.17(m,1H,CH), 3.82(s,3H,OCH 3 ),3.36~3.14(m,6H, piperazine-Hand CH 2 ), 2.56(m,3H, piper...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses N-methyl gatifloxacin aldehyde thiosemicarbazone derivative and a preparation method and application thereof. The N-methyl gatifloxacin aldehyde thiosemicarbazone derivative has a chemical structural formula as a following formula I. In the formula I, substituent R is an H atom or alkyl or cyclopropyl with 1 to 5 carbon atoms. According to the N-methyl gatifloxacin aldehyde thiosemicarbazone derivative disclosed by the invention, combination of three kinds of advantage pharmacophore of a fluoroquinolone framework, imine Schiff base, thiourea and the like is achieved; thus, antineoplastic activity of novel compound is improved, a toxic and side effect of normal cells is reduced, and the N-methyl gatifloxacin aldehyde thiosemicarbazone derivative can serve as antineoplastic activity substance to develop antineoplastic drug with a novel structure.

Description

technical field [0001] The invention belongs to the technical field of new drug discovery and innovative drug synthesis, and specifically relates to a derivative of N-methyl gatifloxacin aldehyde thiosemicarbazone, and also relates to a kind of N-methyl gatifloxacin aldehyde thiosemicarbazone A preparation method of urea derivatives and their application in antitumor drugs. Background technique [0002] The innovation of new drugs originates from the discovery of leads, and the construction of lead molecules based on the combination of dominant pharmacophore skeletons is the most economical and effective strategy. The thiosemicarbazone derivatives constructed from aldehydes or ketones and thiosemicarbazides have attracted much attention because they are easy to form complexes or chelate with macromolecules or metal ions, and exhibit a wide range of pharmacological activities. However, most of the aldehydes or ketones used to construct thiosemicarbazone molecules are common ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/04A61P35/00A61P35/02
CPCC07D401/04
Inventor 胡国强汪学猛杨彤王娜沈睿智
Owner HENAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap